E-LIB Suche - Ergebnisse für: Patrucco, Enrico - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Tyrosine phosphatases regulate resistance to ALK inhibitors..:

Karaca Atabay, Elif ; Mecca, Carmen ; Wang, Qi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814675/. , 2022

Link: http://www.ncbi.nlm.nih...

2

Comparative analysis and isoform-specific therapeutic vulne..:

Ricciuti, Biagio ; Son, Jieun ; Okoro, Jeffrey J...
urn:issn:1078-0432. , 2022

Link: https://orbi.uliege.be/h..

3

Genomic Profiling Identifies Putative Pathogenic Alteration..:

Nicoś, Marcin ; Harbers, Luuk ; Patrucco, Enrico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763853/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Comparative Analysis and Isoform-Specific Therapeutic Vulne..:

Ricciuti, Biagio ; Son, Jieun ; Okoro, Jeffrey J...
info:eu-repo/semantics/altIdentifier/pmid/35091439. , 2022

Link: http://hdl.handle.net/23..

5

Frequent mutations of FBXO11 highlight BCL6 as a therapeuti..:

Pighi, Chiara ; Cheong, Taek-Chin ; Compagno, Mara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153037/. , 2021

Link: http://www.ncbi.nlm.nih...

6

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppress..:

Menotti, Matteo ; Ambrogio, Chiara ; Cheong, Taek-Chin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556382/. , 2018

Link: http://www.ncbi.nlm.nih...

7

Comment on "ALK is a therapeutic target for lethal sepsis":

Blasco, Rafael B ; Patrucco, Enrico ; Mota, Ines..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459396/. , 2018

Link: http://www.ncbi.nlm.nih...

8

Tumor Resistance against ALK Targeted Therapy-Where It Come..:

Sharma, Geeta Geeta ; Mota, Ines ; Mologni, Luca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876637/. , 2018

Link: http://www.ncbi.nlm.nih...

9

Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in..:

Patrucco, Enrico ; Domes, Katrin ; Sbroggió, Mauro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

10

cGMP-dependent kinase 2, Na+/H+ regulatory factor 2, and Na..:

Luo, Min ; Sultan, Ayesha ; Yu, Qin...
http://www.biomedcentral.com/2050-6511/14/S1/O31. , 2013

Link: http://www.biomedcentral..

11

cGMP kinase: past, presence and future:

Hofmann, Franz ; Loga, Florian ; Domes, Katrin..
http://www.biomedcentral.com/2050-6511/14/S1/O11. , 2013

Link: http://www.biomedcentral..

12

Differential effects of PDE5 inhibitors on cardiac dysfunct..:

Rybalkin, Sergei D ; Shimizu, Masami ; Rybalkina, Irina G...
http://www.biomedcentral.com/2050-6511/14/S1/O38. , 2013

Link: http://www.biomedcentral..

13

cAMP-Specific Phosphodiesterases 8A and 8B, Essential Regul..:

Shimizu-Albergine, Masami ; Tsai, Li-Chun Lisa ; Patrucco, Enrico.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310417. , 2012

Link: http://www.ncbi.nlm.nih...

14

Phosphodiesterase 8A, cAMP-specific:

Patrucco, Enrico ; Kraynik, Stephen ; Beavo, Joseph A
qt0w89c7np. , 2012

Link: https://escholarship.org..

15

cGMP kinase I, cardiac hypertrophy and PDE inhibition:

Patrucco, Enrico ; Lukowski, Robert ; Rybalkin, Sergei..
http://www.biomedcentral.com/1471-2210/11/S1/O19. , 2011

Link: http://www.biomedcentral..

1-15